Atıf Formatları
Evaluation of the efficacy of Omalizumab as re-treatment in patients with severe asthma
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. Gençer Tuluy Et Al. , "Evaluation of the efficacy of Omalizumab as re-treatment in patients with severe asthma," American Journal of the Medical Sciences , vol.370, no.1, pp.30-34, 2025

Gençer Tuluy, M. Et Al. 2025. Evaluation of the efficacy of Omalizumab as re-treatment in patients with severe asthma. American Journal of the Medical Sciences , vol.370, no.1 , 30-34.

Gençer Tuluy, M., HAVLUCU, Y., KIZILIRMAK, D., & YORGANCIOĞLU, A. A., (2025). Evaluation of the efficacy of Omalizumab as re-treatment in patients with severe asthma. American Journal of the Medical Sciences , vol.370, no.1, 30-34.

Gençer Tuluy, Müge Et Al. "Evaluation of the efficacy of Omalizumab as re-treatment in patients with severe asthma," American Journal of the Medical Sciences , vol.370, no.1, 30-34, 2025

Gençer Tuluy, Müge G. Et Al. "Evaluation of the efficacy of Omalizumab as re-treatment in patients with severe asthma." American Journal of the Medical Sciences , vol.370, no.1, pp.30-34, 2025

Gençer Tuluy, M. Et Al. (2025) . "Evaluation of the efficacy of Omalizumab as re-treatment in patients with severe asthma." American Journal of the Medical Sciences , vol.370, no.1, pp.30-34.

@article{article, author={Müge Gençer Tuluy Et Al. }, title={Evaluation of the efficacy of Omalizumab as re-treatment in patients with severe asthma}, journal={American Journal of the Medical Sciences}, year=2025, pages={30-34} }